Lars R. Haaheim PhD (1945–2011)
نویسندگان
چکیده
On Tuesday 28 June 2011, Lars Haaheim tragically died whilst on a fishing trip in a fjord near his summer home in Sveio, Norway. Lars was an internationally renowned influenza scientist and a founder member of the International Society for Influenza and Other Respiratory Viruses (isirv). From his formative academic years at the University of Bergen, Lars was an influenza enthusiast. He specialised in ‘host antigens in egg grown influenza virus’ during his graduate degree in 1973, and his PhD project completed in 1981 involved a study of antigenic variation of influenza proteins. In the earlier stages of his career, he was deeply involved and responsible for the production of influenza vaccines in Norway (Norwegian Institute of Public Health, Oslo) and then became Director of the WHO National influenza Centre in Oslo. Lars was a regular contributor to WHO influenza meetings and pioneered serum surveys of Norwegian populations to determine their immune status to new influenza strains. The map of Norway became very familiar to WHO folk when Lars presented his findings. In the 1970’s, Lars spent a year in the influenza laboratories of the National Institute for Biological Standards and Control, UK where he was very much involved with the development of laboratory methods for the study of influenza viruses and vaccines. In 1980, Lars moved to the University of Bergen to become Head of the Immunochemistry Laboratory and more importantly to form the first Influenza Centre at the University. He was Director of the WHO National Influenza Centre for Western Norway in 1982–2001 and was actively involved in preparing the Norwegian Pandemic plan, as well as the first WHO Influenza Pandemic Preparedness Plan. Up to 1 September 2008, Lars was Professor and Head of the Influenza Centre, The Gade Institute, University of Bergen, Norway, and as of 2010, he became a Professor Emeritus at the University of Bergen, teaching immunology. Lars built and enhanced the international reputation of the Influenza Centre, which as of 2002 received annual financial support from the Norwegian Ministry of Health and Care Services. The Influenza Centre gained extensive experience from studies on the kinetics of the post-vaccination humoral and cellular immune response, as well as in mucosal immunity. This expertise made the Influenza Centre an attractive partner in EU Framework Programmes dealing with development of influenza vaccines. Lars patented a technology to detect secretion of antibody by human B lymphocytes and subsequently established a company ‘PlasmAcute AS’ to explore its diagnostic potential. As a result of this earlier work, Lars’ group made ground breaking discoveries of the speed with which human B lymphocytes secrete antibody after influenza vaccination. Early in Lars’ teaching career at the University of Bergen, he realised that there was no satisfactory textbook on virology for the medical students. It exemplifies Lars’ attitude to life that instead of moaning about the situation, he started doing something about it with the result that in 1989 he published with two other colleagues a very successful textbook ‘A Practical Approach to Clinical Virology’. This was revised in 2002, and it is a lasting legacy from Lars to medical students. Lars was an eminent speaker at international scientific conferences. He had a style all of his own, combining humour with scientific rigour, and he was not afraid to take the scientific community to task if action was needed. Lars was acutely aware of our shortcomings in preparing for an influenza pandemic, in particular the plight of small countries with no resident vaccine producer. By bringing this to our attention, Lars has been instrumental in making available ‘swine flu’ pandemic vaccine to countless vulnerable people over the world. Lars has successfully organised several international conferences, most notably the acclaimed series on ‘Immune Correlates of Protective Immunity to Influenza’, the first of which was held in Bergen in 2002 and the most recent with Dr Jackie Katz as a joint organiser of an isirv-sponsored meeting in Miami in 2010. Lars recognised where gaps in our knowledge lay, and he knew the key people and opinion leaders around the world to try to come up with answers. Lars was most recently working with Prof Emanuele Montomoli on an isirv-sponsored ‘Summer School on Influenza’ scheduled DOI: 10.1111/j.1750-2659.2011.00281.x www.blackwellpublishing.com/influenza Obituary
منابع مشابه
Understanding and Preventing Noncontact Anterior Cruciate Ligament Injuries
Letha Y. Griffin,* MD, PhD, Marjorie J. Albohm, MS, ATC, Elizabeth A. Arendt, MD, Roald Bahr, MD, PhD, Bruce D. Beynnon, PhD, Marlene DeMaio, CAPT, MC, USN, Randall W. Dick, MSc, Lars Engebretsen, MD, PhD, William E. Garrett, Jr, MD, PhD, Jo A. Hannafin, MD, PhD, Tim E. Hewett, PhD, Laura J. Huston, MSc, Mary Lloyd Ireland, MD, Robert J. Johnson, MD, Scott Lephart, PhD, ATC, Bert R. Mandelbaum,...
متن کاملImmune correlates of protection against influenza: challenges for licensure of seasonal and pandemic influenza vaccines, Miami, FL, USA, March 1–3, 2010
The emergence of a novel swine-origin pandemic influenza virus in 2009, together with the continuing circulation of highly pathogenic avian H5N1 viruses and the urgent global need to produce effective vaccines against such public health threats, has prompted a renewed interest in improving our understanding of the immune correlates of protection against influenza. As new influenza vaccine techn...
متن کاملValvular Heart Disease Health-Related Quality of Life After Transcatheter Aortic Valve Replacement in Inoperable Patients With Severe Aortic Stenosis
Matthew R. Reynolds, MD, MSc; Elizabeth A. Magnuson, ScD; Yang Lei, MSc; Martin B. Leon, MD; Craig R. Smith, MD; Lars G. Svensson, MD, PhD; John G. Webb, MD; Vasilis C. Babaliaros, MD; Bruce S. Bowers, MD; William F. Fearon, MD; Howard C. Herrmann, MD; Samir Kapadia, MD; Susheel K. Kodali, MD; Raj R. Makkar, MD; Augusto D. Pichard, MD; David J. Cohen, MD, MSc; for the Placement of Aortic Transc...
متن کاملEffect of Telmisartan on Renal Outcomes
Johannes F.E. Mann, MD; Roland E. Schmieder, MD; Leanne Dyal, MSc; Matthew J. McQueen, MD; Helmut Schumacher, MD; Janice Pogue, PhD; Xingyu Wang, PhD; Jeffrey L. Probstfield, MD; Alvaro Avezum, MD, PhD; Ernesto Cardona-Munoz, PhD; Gilles R. Dagenais, MD; Rafael Diaz, MD; George Fodor, MD, PhD; Jean M. Maillon, MD; Lars Rydén, MD; Cheuk M. Yu, MD; Koon K. Teo, MD; and Salim Yusuf, DPh, MD, for t...
متن کامل